Illustrative image – not actual.Xechem
International Inc, a New Jersey-based company, has plans to set up a 100 per
cent export-oriented facility to manufacture anti-cancer compounds and drugs
using medicinal plants and trees at Siruseri in Tamil Nadu. The plant would produce
60 kg of paclitaxel annually, half of which used to make nine anti-cancer
formulations.
The
facility would come up on 40 acres of land at the Biotech Park for which the
State Industries Promotion Corporation of Tamil Nadu has acquired land.
The
project would be set up in phases. The first phase would entail an investment of
Rs.100 crore, while the second phase the company would involve an investment of
Rs.50 crore for setting up a R & D centre. The machinery and the equipment,
most of which would be imported, would cost about Rs.30 crore.
A new company - Xechem Pharmaceuticals India, would be set up, in which Xechem International is likely to hold up to 80 per cent equity. The project would have a debt equity ratio of 1:1. The Tamil Nadu Industrial Development Corporation is also likely to take up stake in the project. The plant would commence operations within 20 months from October 2002.
